Developing novel iron chaperone therapies for orphan iron dysregulation disorders. Our approach targets the pathological iron maldistribution that drives disease progression in rare conditions where no treatments currently exist.
ChapIRONe Therapeutics Limited
8-12 York Gate, 100 Marylebone Road
London NW1 5DX
United Kingdom
8-12 York Gate, 100 Marylebone Road
London NW1 5DX
United Kingdom